Literature DB >> 18695675

Functional long-range interactions of the IgH 3' enhancers with the bcl-2 promoter region in t(14;18) lymphoma cells.

H Duan1, H Xiang, L Ma, L M Boxer.   

Abstract

To better understand the mechanisms underlying the role of the immunoglobulin heavy-chain gene (IgH) 3' enhancers on bcl-2 transcriptional deregulation in t(14;18) lymphoma, we characterized the physical interactions of the IgH 3' enhancer region with the bcl-2 promoters. Using the chromosome conformation capture technique, we found that the IgH 3' enhancers physically interact with the bcl-2 promoter region over a 350 kb genomic region in t(14;18) lymphoma cells. No interactions of the bcl-2 promoter region with sequences distant to the IgH enhancers were observed. The physical interactions of the IgH enhancers with the bcl-2 5' region are functionally involved in the transcriptional control of bcl-2. The histone deacetylase inhibitor, trichostatin A, repressed bcl-2 transcription and decreased the IgH enhancer-bcl-2 promoter region interactions. We showed by chromatin immunoprecipitation assay and small interference RNA transfection studies that the POU2 family transcription factor Oct-2 and its cofactor Bob-1 have an important function in mediating the IgH enhancer-bcl-2 promoter region interactions. This study reveals a new aspect of the regulatory role of the IgH 3' enhancers on bcl-2 transcription in t(14;18) lymphomas.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18695675      PMCID: PMC2613909          DOI: 10.1038/onc.2008.286

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  25 in total

1.  Quantitative analysis of chromosome conformation capture assays (3C-qPCR).

Authors:  Hélène Hagège; Petra Klous; Caroline Braem; Erik Splinter; Job Dekker; Guy Cathala; Wouter de Laat; Thierry Forné
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

2.  Expression of Bcl-2 and Bcl-2-Ig fusion transcripts in normal and neoplastic cells.

Authors:  W B Graninger; M Seto; B Boutain; P Goldman; S J Korsmeyer
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

3.  Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells.

Authors:  L Madisen; M Groudine
Journal:  Genes Dev       Date:  1994-09-15       Impact factor: 11.361

4.  Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death.

Authors:  D Hockenbery; G Nuñez; C Milliman; R D Schreiber; S J Korsmeyer
Journal:  Nature       Date:  1990-11-22       Impact factor: 49.962

5.  Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis.

Authors:  B E Wilson; E Mochon; L M Boxer
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

6.  Regulation of chemoresistance by the bcl-2 oncoprotein in non-Hodgkin's lymphoma and lymphocytic leukemia cell lines.

Authors:  J C Reed; S Kitada; S Takayama; T Miyashita
Journal:  Ann Oncol       Date:  1994       Impact factor: 32.976

7.  Evidence for physical interaction between the immunoglobulin heavy chain variable region and the 3' regulatory region.

Authors:  Zhongliang Ju; Sabrina A Volpi; Rabih Hassan; Nancy Martinez; Sandra L Giannini; Tamar Gold; Barbara K Birshtein
Journal:  J Biol Chem       Date:  2007-10-05       Impact factor: 5.157

Review 8.  Anticancer drug resistance and inhibition of apoptosis.

Authors:  B Desoize
Journal:  Anticancer Res       Date:  1994 Nov-Dec       Impact factor: 2.480

9.  CREB proteins function as positive regulators of the translocated bcl-2 allele in t(14;18) lymphomas.

Authors:  L Ji; E Mochon; M Arcinas; L M Boxer
Journal:  J Biol Chem       Date:  1996-09-13       Impact factor: 5.157

10.  Alternative promoters and exons, somatic mutation and deregulation of the Bcl-2-Ig fusion gene in lymphoma.

Authors:  M Seto; U Jaeger; R D Hockett; W Graninger; S Bennett; P Goldman; S J Korsmeyer
Journal:  EMBO J       Date:  1988-01       Impact factor: 11.598

View more
  20 in total

1.  BCL6 promoter interacts with far upstream sequences with greatly enhanced activating histone modifications in germinal center B cells.

Authors:  Himabindu Ramachandrareddy; Alyssa Bouska; Yulei Shen; Ming Ji; Angie Rizzino; Wing C Chan; Timothy W McKeithan
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-14       Impact factor: 11.205

Review 2.  Enhancer-promoter communication and transcriptional regulation of Igh.

Authors:  Ananda L Roy; Ranjan Sen; Robert G Roeder
Journal:  Trends Immunol       Date:  2011-08-19       Impact factor: 16.687

3.  Mouse model of endemic Burkitt translocations reveals the long-range boundaries of Ig-mediated oncogene deregulation.

Authors:  Alexander L Kovalchuk; Camilo Ansarah-Sobrinho; Ofir Hakim; Wolfgang Resch; Helena Tolarová; Wendy Dubois; Arito Yamane; Makiko Takizawa; Isaac Klein; Gordon L Hager; Herbert C Morse; Michael Potter; Michel C Nussenzweig; Rafael Casellas
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-18       Impact factor: 11.205

4.  Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma.

Authors:  Hongxiu Li; Mark S Kaminski; Yifeng Li; Mehmet Yildiz; Peter Ouillette; Siân Jones; Heather Fox; Kathryn Jacobi; Kamlai Saiya-Cork; Dale Bixby; Daniel Lebovic; Diane Roulston; Kerby Shedden; Michael Sabel; Lawrence Marentette; Vincent Cimmino; Alfred E Chang; Sami N Malek
Journal:  Blood       Date:  2014-01-16       Impact factor: 22.113

5.  Discovery platform for inhibitors of IgH gene enhancer activity.

Authors:  Nathan G Dolloff
Journal:  Cancer Biol Ther       Date:  2018-11-27       Impact factor: 4.742

6.  Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma.

Authors:  Russell J H Ryan; Yotam Drier; Holly Whitton; M Joel Cotton; Jasleen Kaur; Robbyn Issner; Shawn Gillespie; Charles B Epstein; Valentina Nardi; Aliyah R Sohani; Ephraim P Hochberg; Bradley E Bernstein
Journal:  Cancer Discov       Date:  2015-07-30       Impact factor: 39.397

7.  Chromatin conformation signatures of cellular differentiation.

Authors:  James Fraser; Mathieu Rousseau; Solomon Shenker; Maria A Ferraiuolo; Yoshihide Hayashizaki; Mathieu Blanchette; Josée Dostie
Journal:  Genome Biol       Date:  2009-04-19       Impact factor: 13.583

8.  Development of Dual Functional Nucleic Acid Delivery Nanosystem for DNA Induced Silencing of Bcl-2 Oncogene.

Authors:  Somayeh Karimi; Mohamad Hassan Fouani; Ahmad Moshaii; Maryam Nikkhah; Saman Hosseinkhani; Reza Sheikhnejad
Journal:  Int J Nanomedicine       Date:  2020-03-10

9.  A novel SATB1 binding site in the BCL2 promoter region possesses transcriptional regulatory function.

Authors:  Feiran Gong; Luan Sun; Yujie Sun
Journal:  J Biomed Res       Date:  2010-11

10.  The role of master regulators in the metabolic/transcriptional coupling in breast carcinomas.

Authors:  Karol Baca-López; Miguel Mayorga; Alfredo Hidalgo-Miranda; Nora Gutiérrez-Nájera; Enrique Hernández-Lemus
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.